Bruno Amati
Impact in
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Cancer-related gene regulation
- RNA Research and Splicing
- DNA Repair Mechanisms
- Oncology top 0.5%
- Cancer-related Molecular Pathways
Papers in
-
- Genomics and Chromatin Dynamics 27
- Ubiquitin and proteasome pathways 25
- Epigenetics and DNA Methylation 20
- RNA Research and Splicing 13
- RNA modifications and cancer 12
- Cancer-related gene regulation 8
- Protein Degradation and Inhibitors 6
- Oncology 30
- Cancer-related Molecular Pathways 23
- Co-authors
- Hartmut Land (8 shared papers)Scott R. Frank (6 shared papers)Gérard I. Evan (7 shared papers)Arianna Sabò (19 shared papers)Trevor D. Littlewood (6 shared papers)Paula Fernández (4 shared papers)Susan M. Gasser (6 shared papers)Marianne Schroeder (2 shared papers)
- Journals
- Oncogene (7 papers)The EMBO Journal (6 papers)Nature Cell Biology (5 papers)Nature (4 papers)Oncotarget (4 papers)
- Partner nations
- ItalyUnited StatesUnited Kingdom
In The Last Decade
Bruno Amati
93 papers receiving 10.5k citations
Bruno Amati's Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 9.1k
- Oncology 2.9k
- Cancer Research 1.4k
- Aging 104
- Cell Biology 940
Countries citing papers authored by Bruno Amati
This map shows the geographic impact of Bruno Amati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Amati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Amati more than expected).
Fields of papers citing papers by Bruno Amati
This network shows the impact of papers produced by Bruno Amati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Amati. The network helps show where Bruno Amati may publish in the future.
Co-authors
The 25 scholars most cited alongside Bruno Amati, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic targets of the human c-Myc protein Hit paper breakdown → | 2003 | 764 |
| 2 | 1993 | 456 | |
| 3 | 2001 | 424 | |
| 4 | 1992 | 382 | |
| 5 | 2007 | 368 | |
| 6 | 2014 | 354 | |
| 7 | 2015 | 350 | |
| 8 | 1993 | 331 | |
| 9 | 1998 | 323 | |
| 10 | 1994 | 322 | |
| 11 | 2004 | 318 | |
| 12 | 2006 | 299 | |
| 13 | 2003 | 296 | |
| 14 | 2011 | 295 | |
| 15 | 1996 | 291 | |
| 16 | 2015 | 266 | |
| 17 | 2012 | 256 | |
| 18 | 2006 | 248 | |
| 19 | 1988 | 217 | |
| 20 | 2009 | 207 |
About Bruno Amati
Bruno Amati is a scholar working on Molecular Biology, Oncology, Immunology, Cell Biology and Oceanography, having authored 94 papers that have together received 10.7k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (27 papers), Ubiquitin and proteasome pathways (25 papers), Cancer-related Molecular Pathways (23 papers), Epigenetics and DNA Methylation (20 papers), RNA Research and Splicing (13 papers), RNA modifications and cancer (12 papers), Cancer-related gene regulation (8 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Molecular Biology (9.1k citations), Oncology (2.9k citations), Cancer Research (1.4k citations), Aging (104 citations) and Cell Biology (940 citations). Bruno Amati has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Hartmut Land, Scott R. Frank, Gérard I. Evan, Arianna Sabò, Trevor D. Littlewood, Paula Fernández, Susan M. Gasser, Marianne Schroeder, Ernesto Guccione and Stefan Taubert. Their work appears in journals such as Oncogene, The EMBO Journal, Nature Cell Biology, Nature and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.